These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6824673)

  • 1. Investigation of sesquiterpene lactones as protein synthesis inhibitors of P-388 lymphocytic leukemia cells.
    Liou YF; Hall IH; Lee KH; Williams WL; Chaney SG
    Biochim Biophys Acta; 1983 Mar; 739(2):190-6. PubMed ID: 6824673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indirect inactivation of rabbit reticulocyte initiation factor eIF-2 by helenalin and bis(helenalinyl) malonate.
    Williams WL; Chaney SG; Hall IH; Lee KH
    Biochemistry; 1984 Nov; 23(23):5637-44. PubMed ID: 6095903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of nucleic acid synthesis in P-388 lymphocytic leukemia cells in culture by sesquiterpene lactones.
    Hall IH; Williams WL; Grippo AA; Lee KH; Holbrook DJ; Chaney SG
    Anticancer Res; 1988; 8(1):33-42. PubMed ID: 2895992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of nucleic acid synthesis in P-388 lymphocytic leukemia tumor cells by helenalin and bis(helenalinyl)malonate in vivo.
    Williams WL; Hall IH; Grippo AA; Oswald CB; Lee KH; Holbrook DJ; Chaney SG
    J Pharm Sci; 1988 Feb; 77(2):178-84. PubMed ID: 2896234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor agents XLVIII: Structure-activity relationships of quassinoids as in vitro protein synthesis inhibitors of P-388 lymphocytic leukemia tumor cell metabolism.
    Liou YF; Hall IH; Okano M; Lee KH; Chaney SG
    J Pharm Sci; 1982 Apr; 71(4):430-5. PubMed ID: 7086652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of helenalin and bis(helenalinyl)malonate on nucleic acid and protein synthesis in human KB carcinoma cells.
    Hall IH; Grippo AA; Lee KH; Chaney SG; Holbrook DJ
    Pharm Res; 1987 Dec; 4(6):509-14. PubMed ID: 2907784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor agents 68: effects of a series of helenalin derivatives on P-388 lymphocytic leukemia nucleic acid and protein synthesis.
    Hall IH; Williams WL; Chaney SG; Gilbert CJ; Holbrook DJ; Muraoka O; Kiyokawa H; Lee KH
    J Pharm Sci; 1985 Mar; 74(3):250-4. PubMed ID: 2861271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor agents XLVII: The effects of bisbrusatolyl malonate on P-388 lymphocytic leukemia cell metabolism.
    Hall IH; Liou YF; Lee KH; Okano M; Chaney SG
    J Pharm Sci; 1982 Feb; 71(2):257-62. PubMed ID: 6278124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor agents XLII: Comparison of antileukemic activity of helenalin, brusatol, and bruceantin and their esters on different strains of P-388 lymphocytic leukemic cells.
    Hall IH; Lee KH; Okano M; Sims D; Ibuka T; Liou YF; Imakura Y
    J Pharm Sci; 1981 Oct; 70(10):1147-50. PubMed ID: 7299649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of decrease of protein synthesis by sodium cyanate in murine P388 leukemia cells.
    Lazarus P; Panasci LC
    Cancer Res; 1987 Oct; 47(19):5102-7. PubMed ID: 3621195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of inosine monophosphate dehydrogenase by sesquiterpene lactones.
    Page JD; Chaney SG; Hall IH; Lee KH; Holbrook DJ
    Biochim Biophys Acta; 1987 Nov; 926(2):186-94. PubMed ID: 2889474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inactivation of rabbit reticulocyte initiation factor eIF-3 by helenalin.
    Williams WL; Chaney SG; Willingham W; Considine RT; Hall IH; Lee KH
    Biochim Biophys Acta; 1983 Jun; 740(2):152-62. PubMed ID: 6860667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor agents LVI: the protein synthesis inhibition by genkwadaphnin and yuanhuacine of P-388 lymphocytic leukemia cells.
    Liou YF; Hall IH; Lee KH
    J Pharm Sci; 1982 Dec; 71(12):1340-4. PubMed ID: 7153880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor agents. 21. A proposed mechanism for inhibition of cancer growth by tenulin and helenalin and related cyclopentenones.
    Hall IH; Lee KH; Mar EC; Starnes CO; Waddell TG
    J Med Chem; 1977 Mar; 20(3):333-7. PubMed ID: 845864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor agents LIX: effects of quassinoids on protein synthesis of a number of murine tumors and normal cells.
    Hall IH; Liou YF; Lee KH; Chaney SG; Willingham W
    J Pharm Sci; 1983 Jun; 72(6):626-30. PubMed ID: 6875823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cytotoxicity of helenalin, its mono and difunctional esters, and related sesquiterpene lactones in murine and human tumor cells.
    Grippo AA; Hall IH; Kiyokawa H; Muraoka O; Shen YC; Lee KH
    Drug Des Discov; 1992 Feb; 8(3):191-206. PubMed ID: 1525302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity and mechanism of action of the novel marine natural products mycalamide-A and -B and onnamide.
    Burres NS; Clement JJ
    Cancer Res; 1989 Jun; 49(11):2935-40. PubMed ID: 2720652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor agents XXX: Evaluation of alpha-methylene-gamma-lactone-containing agents for inhibition of tumor growth, respiration, and nucleic acid synthesis.
    Hall IH; Lee KH; Starnes CO; Eigebaly SA; Ibuka T; Wu YS; Kimura T; Haruna M
    J Pharm Sci; 1978 Sep; 67(9):1235-9. PubMed ID: 690826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor inhibitors. 69. Structure-cytotoxicity relationships among the sesquiterpene lactones.
    Kupchan SM; Eakin MA; Thomas AM
    J Med Chem; 1971 Dec; 14(12):1147-52. PubMed ID: 5116225
    [No Abstract]   [Full Text] [Related]  

  • 20. Overcoming drug resistance in cancer cells with synthetic isoprenoids.
    Yamaguchi T; Nakagawa M; Shiraishi N; Yoshida T; Kiyosue T; Arita M; Akiyama S; Kuwano M
    J Natl Cancer Inst; 1986 May; 76(5):947-53. PubMed ID: 3457980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.